TET2 and acute myeloid leukemia: In these large cohort studies, DNMT3A and TET2 mutations appeared as commonly occurring events in both AML and control cases, but higher VAFs (> 10%), the presence of a higher number of variants (two or more), along with clonal complexity, correlated with a greater risk of AML [53•, 54•].